TOPIC: Fundamentals of Idiopathic Pulmonary Fibrosis (IPF) - Navigating the Patient Journey
SPEAKER: Paul Noble, MD
Dr. Noble's clinical areas of expertise are interstitial lung disease, conducting clinical trials in idiopathic pulmonary fibrosis, connective tissue disease-related pulmonary disease and brochiolitis. His research focuses on cellular and molecular mechanisms of lung inflammation and fibrosis, the role of lung stem cells in pulmonary fibrosis and the role of host defense in lung inflammation and fibrosis. He is heavily supported by the National Heart, Lung and Blood Institute at the National Institutes of Health.
A prolific author, Dr. Noble has been published in numerous peer-review journals, including the New England Journal of Medicine, Science and Nature Medicine. As deputy editor of the Journal of Clinical Investigation, he has been a leading contributor to discovery in lung disease. An elected member of the American Society of Clinical Investigation and the American Association of Physicians, he is currently deputy editor of the Journal of Clinical Investigation and has been a member of the editorial boards for the American Journal of Respiratory Cell and Molecular Biology and the American Journal of Respiratory and Critical Care Medicine. He also has been a member of the scientific advisory board of the American Asthma Foundation.
After earning his bachelor’s degree at Haverford College and his medical degree from New York University School of Medicine, Dr. Noble completed his residency and was chief resident in internal medicine at the University of California, San Francisco. He completed pulmonary and critical care fellowships at the University of Colorado Health Sciences Center and the National Jewish Center for Immunology and Respiratory Medicine.
Prior to joining Cedars-Sinai, Dr. Noble was the Charles Johnson, MD, Distinguished Professor and Chief of the Division of Pulmonary, Allergy and Critical Care Medicine at Duke University Medical Center in Durham, N.C.
As an assistant professor of medicine at Johns Hopkins University School of Medicine, he was founder and director of the Interstitial Lung Disease Clinic, before moving on to become professor of medicine and associate chief of pulmonary and critical care at Yale University School of Medicine. At Yale, he also formed an interstitial lung disease clinic and, at Duke, he propelled his division to the highest ranks in the nation for clinical care, research productivity and NIH funding.
The DOM Research Seminars – launched in September 2016 – pair a junior and senior investigator from different divisions to highlight the breadth and variety of innovative research efforts being accomplished in the University of Arizona, Department of Medicine at the UA College of Medicine – Tucson.
This lecture series occurs on the second Thursday of the month. Each lecture is webcast live via the UA Health Sciences BioCommunications website and archived for viewing later at: http://streaming.biocom.arizona.edu/home/(click on the date to watch).
UAHS 5403 and Banner-UMC-SC 3030